105 related articles for article (PubMed ID: 2472470)
1. Immunologic determinants of head and neck cancer response to induction chemotherapy.
Schantz SP; Savage HE; Racz T; Liu FJ; Brown BW; Rossen RD; Hong WK
J Clin Oncol; 1989 Jul; 7(7):857-64. PubMed ID: 2472470
[TBL] [Abstract][Full Text] [Related]
2. Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy.
Recondo G; Armand JP; Tellez-Bernal E; Domenge C; Belehradek M; De Vathaire F; Wibault P; Richard JM; Cvitkovic E
Laryngoscope; 1991 May; 101(5):494-501. PubMed ID: 1709437
[TBL] [Abstract][Full Text] [Related]
3. [Alteration of immunological parameters following CDDP-5-FU chemotherapy].
Tsukuda M; Kubota A; Yosida T; Miyata K; Sawaki S
Gan To Kagaku Ryoho; 1988 Nov; 15(11):3163-6. PubMed ID: 3190253
[No Abstract] [Full Text] [Related]
4. Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer.
Cognetti F; Pinnarö P; Ruggeri EM; Carlini P; Perrino A; Impiombato FA; Calabresi F; Chilelli MG; Giannarelli D
J Clin Oncol; 1989 Jul; 7(7):829-37. PubMed ID: 2472469
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin and 5-fluorouracil as neoadjuvant chemotherapy: predicting response in head and neck squamous cell cancer.
Wang HM; Wang CH; Chen JS; Chang HK; Kiu MC; Liaw CC; Ng KT; Lai GM
J Formos Med Assoc; 1995 Mar; 94(3):87-94. PubMed ID: 7613250
[TBL] [Abstract][Full Text] [Related]
6. Treatment of squamous-cell carcinoma of the head and neck with cisplatin and 5-fluorouracil.
Amrein PC; Weitzman SA
J Clin Oncol; 1985 Dec; 3(12):1632-9. PubMed ID: 2415693
[TBL] [Abstract][Full Text] [Related]
7. Circulating immune complexes and chemotherapy response in patients with head and neck cancer.
Blazar BA; Fried MP; Strome M; Clark JR; Sereno P; Rodliff S; Caminear D
Head Neck; 1989; 11(5):431-6. PubMed ID: 2807883
[TBL] [Abstract][Full Text] [Related]
8. [Chemotherapy of head and neck cancer].
Kohno N; Nakazawa E; Kusunoki M; Nishiya M
Gan To Kagaku Ryoho; 1996 Feb; 23(3):277-82. PubMed ID: 8712819
[TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
Forastiere AA; Metch B; Schuller DE; Ensley JF; Hutchins LF; Triozzi P; Kish JA; McClure S; VonFeldt E; Williamson SK
J Clin Oncol; 1992 Aug; 10(8):1245-51. PubMed ID: 1634913
[TBL] [Abstract][Full Text] [Related]
10. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
Amrein PC; Fabian RL
Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
[TBL] [Abstract][Full Text] [Related]
11. Rate of pathologic complete responses to docetaxel, cisplatin, and fluorouracil induction chemotherapy in patients with squamous cell carcinoma of the head and neck.
Haddad R; Tishler R; Wirth L; Norris CM; Goguen L; Sullivan C; O'Donnell L; Li Y; Posner M
Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):678-81. PubMed ID: 16785415
[TBL] [Abstract][Full Text] [Related]
12. Alternating combination chemotherapy using cisplatin-bleomycin with sequential methotrexate-5-FU plus leucovorin rescue in patients with head and neck cancer.
Panasci L; Gravenor D; Black M; Frenkiel S; Margolese R
Cancer Treat Rep; 1985 Sep; 69(9):1015-7. PubMed ID: 2411401
[TBL] [Abstract][Full Text] [Related]
13. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
[TBL] [Abstract][Full Text] [Related]
14. Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial.
Colevas AD; Busse PM; Norris CM; Fried M; Tishler RB; Poulin M; Fabian RL; Fitzgerald TJ; Dreyfuss A; Peters ES; Adak S; Costello R; Barton JJ; Posner MR
J Clin Oncol; 1998 Apr; 16(4):1331-9. PubMed ID: 9552034
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of squamous cell carcinoma of the head and neck with multi-drug chemotherapy and radiotherapy].
Nishio M; Kagami Y; Narimatsu N; Asano K; Sanbe S; Somekawa Y
Gan To Kagaku Ryoho; 1989 Sep; 16(9):3111-8. PubMed ID: 2476971
[TBL] [Abstract][Full Text] [Related]
16. Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results.
Clark JR; Busse PM; Norris CM; Andersen JW; Dreyfuss AI; Rossi RM; Poulin MD; Colevas AD; Tishler RB; Costello R; Lucarini JW; Lucarini D; Thornhill L; Lackey M; Peters E; Posner MR
J Clin Oncol; 1997 Sep; 15(9):3100-10. PubMed ID: 9294473
[TBL] [Abstract][Full Text] [Related]
17. Association of levels of circulating C1q binding macromolecules with induction chemotherapy response in head and neck cancer patients.
Schantz SP; Savage HE; Brown BW; Reuben JM; Hong WK; Rossen RD
Cancer Res; 1988 Oct; 48(20):5868-73. PubMed ID: 3262415
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary evaluation of the effectiveness of induction chemotherapy with cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the head and neck].
Migdał K; Korzeniowski S; Skołyszewski J
Otolaryngol Pol; 1991; 45(2):85-9. PubMed ID: 2067863
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
[TBL] [Abstract][Full Text] [Related]
20. Cisplatin and 5-FU infusions in therapy of advanced squamous cell carcinoma of head and neck in 50 Indian patients.
Sharma SC; Sharma AK; Singhal KC
Zhongguo Yao Li Xue Bao; 1990 May; 11(3):288. PubMed ID: 2088008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
